Status:

UNKNOWN

mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer

Lead Sponsor:

Sun Yat-sen University

Conditions:

Colorectal Cancer

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The current standard treatment for locally advanced rectal cancer is still fluorouracil-based neoadjuvant radiotherapy and chemotherapy followed by TME surgery, followed by adjuvant chemotherapy. Fluo...

Detailed Description

This trial is a two-arm, multicenter, open labelled, prospective, randomized phase III studies. Eligible patients with locally advnaced colorectal cancer receiving oxlipaltin-based (less than 3 months...

Eligibility Criteria

Inclusion

  • Age 18-70 years
  • ECOG PS 0-1
  • Exposure to Oxaliplatin in preoperative treatment (less than 3 months)
  • Induction or consolidation chemotherapy in rectal cancer or Concurrent FOLFOX with CRT in rectal cancer
  • Neoadjuvant treatment with CAPOX or FOLFOX in colon cancer
  • Curative surgery (R0 resection)
  • ypStage IIB, IIC and ypStage III
  • No distant metastasis after surgery
  • ≤ 8 weeks prior to randomization

Exclusion

  • Previous or concurrent cancer that is distinct in primary site or histology from colon cancer within 5 years prior to randomization.
  • Significant cardiovascular disease including unstable angina or myocardial infarction within 6 months before initiating study treatment.
  • Heart failure grade III/IV (NYHA-classification).
  • Unresolved toxicity higher than CTCAE v.4.0 Grade 1 attributed to any prior therapy/procedure.
  • Subjects with known allergy to the study drugs or to any of its excipients.
  • Current or recent (within 4 weeks prior to starting study treatment) treatment of another investigational drug or participation in another investigational study.
  • Breast- feeding or pregnant women
  • Lack of effective contraception

Key Trial Info

Start Date :

April 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2025

Estimated Enrollment :

638 Patients enrolled

Trial Details

Trial ID

NCT04338191

Start Date

April 1 2020

End Date

February 1 2025

Last Update

December 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gastrointestinal Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China, 510655

mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer | DecenTrialz